Welcome to the e-CCO Library!

P307: Modelling of the relationship between ustekinumab exposure, faecal calprotectin and endoscopic outcomes in patients with Crohn’s disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Wang, Z.(1);Verstockt, B.(2,3);Vermeire, S.(2,3);Sabino, J.(2,3);Ferrante, M.(2,3);Declerck, P.(1);Dreesen, E.(1,4);
Created: Wednesday, 2 June 2021, 4:12 PM
P307: Safety, efficacy, and pharmacokinetics of golimumab in patients with moderately to severely Active ulcerative colitis: PURSUIT-SC long-term extension
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

W. Reinisch*1, P. Gibson2, W. J. Sandborn3, B. Feagan4, C. Marano5, R. Strauss5, J. Johanns5, H. Zhang5, L. Padgett5, O. J. Adedokun5, J.-F. Colombel6, J. Collins7, P. Rutgeerts8, D. Tarabar9

Created: Friday, 22 February 2019, 9:49 AM
P307: Study of the proteomic profile in patients with ulcerative colitis, its correlation with diagnosis and disease activity
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. Ahmed1*, S. Badr El-Din1, D. Header1, P. Moez2, M. Ibrahim3

Created: Thursday, 21 February 2019, 9:14 AM
P307: The effect of COVID-19 infection and vaccination in patients with Inflammatory Bowel Disease and Irritable Bowel Syndrome.
Year: 2022
Source: ECCO'22
Authors: Sciberras, N.(1);Pisani, A.(2);Vassallo, C.(1);Zahra Bianco, E.(2);Ellul, P.(2);
Created: Friday, 11 February 2022, 3:52 PM
P307: The use of the patient safety form in patients with inflammatory bowel disease, can improve the low screening and starting HBV prophylaxis rates in real life
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Demir*1, E. Uçar2, M. M. Çelik2

Created: Friday, 22 February 2019, 9:41 AM
P308 The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Kutschera1, T. Waldhör2, H.P. Gröchenig3, T. Haas4, H. Wenzl5, P. Steiner6, R. Koch7, T. Feichtenschlager8, G. Eckhardt9, A. Mayer10, A. Kirchgatterer11, O. Ludwiczek12, R. Platzer13, P. Papay14, J. Gartner15, H. Fuchssteiner16, P.G. Peters17, G. Reicht18, G. Moser1, C. Dejaco1, C. Primas1, G. Novacek1, W. Miehsler19, Austrian IBD Study Group (ATISG)

Created: Thursday, 30 January 2020, 10:12 AM
P308: A new endoscopic scoring system corresponding to histological healing using linked color imaging in ulcerative colitis: SOUL study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Saito, D.(1)*;Hirai, F.(2);Uchiyama, K.(3);Takagi, T.(3);Naito, Y.(4);Takatsu, N.(5);Tanabe, H.(6);Kishimoto, M.(7);Matsuura, M.(1);Miyoshi, J.(1);Watanabe, K.(8);Esaki, M.(9);Naganuma, M.(10);Hisamatsu, T.(1);
Created: Friday, 14 July 2023, 11:05 AM
P308: Continued statural growth In older adolescents and young adults with Crohn’s disease and ulcerative colitis beyond the time of expected growth plate closure
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Gupta1*, E. King2, C. Liu2, F. Sylvester3, D. Lee4, B. Boyle5, A. Trauernicht6, S. Chen2, J. Pratt2, R. Colletti7, ImproveCareNow Network

Created: Thursday, 21 February 2019, 9:14 AM
P308: Effectiveness and Safety of tofacitinib for the Treatment of Ulcerative Colitis: A Single-Arm Meta-analysis of Observational Studies
Year: 2021
Source: ECCO'21 Virtual
Authors: Macaluso, F.S.(1);Maida, M.(2);Ventimiglia, M.(1);Orlando, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P308: Predictors of loss of response to adalimumab therapy: the importance of therapeutic drug monitoring in inflammatory bowel diseases
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Z. Kurti*1, Z. Vegh1, M. Rutka2, L. Gonczi1, K. Farkas2, K. Gecse1, P. A. Golovics1, B. Szalay3, T. Molnar2, P. Lakatos1

Created: Friday, 22 February 2019, 9:49 AM
P308: Quadruple oral antibiotic treatment in refractory Paediatric Inflammatory Bowel Disease – incidence and analysis of responders from a 10 year cohort.
Year: 2022
Source: ECCO'22
Authors: Meredith, J.J.(1,2);Armstrong, K.(1);Russell, R.K.(1,2);Henderson, P.(1,2);Wilson, D.C.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
P308: Safety of the given patency capsule in patients with Crohn's disease or suspected Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Silva M., Cardoso H., Peixoto A., Nunes A.C.-R., Marques M., Lopes S., Magro F., Macedo G.

Created: Wednesday, 20 February 2019, 10:36 AM
P308: Utility of bowel ultrasound in diagnosing disease activity in Crohn’s disease: Indian experience
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. Kakkadasam Ramaswamy*1, K. V. Nagarajan1, A. Yelsangikar1, A. Nagar1, N. Bhat1

Created: Friday, 22 February 2019, 9:41 AM
P309 Ferritin or transferrin saturation vs. soluble transferrin receptor for iron deficiency diagnosis in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. DAUDE1, T. Remen2, T. Chateau3, S. Danese4, I. Gastin5, C. Baumann6, J.L. Gueant5, L. Peyrin-Biroulet1

Created: Thursday, 30 January 2020, 10:12 AM
P309: Accuracy of PanMayo endoscopic score in predicting long-term disease outcomes in ulcerative colitis– a promising scoring system
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Bacsur, P.(1)*;Wetwittayakhlang, P.(2);Resál, T.(1);Rutka, M.(1);Bessissow, T.(2);Atif, W.(2);Bálint, A.(1);Fábián, A.(1);Bor, R.(1);Szepes, Z.(1);Farkas, K.(1);Lakatos, P.L.(2,3);Molnár, T.(1);
Created: Friday, 14 July 2023, 11:05 AM
P309: Are results from VARSITY applicable to real world? Adalimumab versus vedolizumab as first line biological in moderate-to-severe IBD.
Year: 2021
Source: ECCO'21 Virtual
Authors: Moens, A.(1,2);Verstockt, B.(1,2);Alsoud, D.(2);Sabino, J.(1,2);Ferrante, M.(1,2);Vermeire, S.(1,2);
Created: Wednesday, 2 June 2021, 4:12 PM
P309: Faecal calprotectin and plasma cytokines in the prediction of early postoperative Crohn’s disease recurrence
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. Cerrillo1*, I. Moret2, M. Iborra1, D. Hervás3, L. Tortosa1, E. Sáez-González1, P. Nos1, B. Beltrán1

Created: Thursday, 21 February 2019, 9:14 AM
P309: High infliximab trough levels are associated with better control of inflammation in inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

D. Drobne*1, T. Kurent1, P. Rajar2, M. Slak3, M. Kozelj1, G. Novak1, N. Smrekar1, S. Plut1, A. Smid1, J. Osredkar4, B. Stabuc1, I. Ferkolj1

Created: Friday, 22 February 2019, 9:49 AM
P309: Impact of co-morbidities on loss and lack of response to anti-TNFs in inflammatory bowel disease: VERNE study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

I. Marín-Jiménez*1,2, G. Bastida3,4, A. Forés5, E. García-Planella6, F. Argüelles-Arias7, P. Sarasa8, I. Tagarro8, A. Fernández-Nistal8, C. Montoto8, M. Aguas3,4, J. Santos-Fernández9, M. Boscá10, R. Ferreiro-Iglesias11, O. Merino12, X. Aldeguer13, X. Cortés14,15, B. Sicilia16, F. Mesonero17, M. Barreiro-de Acosta11

Created: Friday, 22 February 2019, 9:41 AM
P309: Impact of rapid access MR on clinical decision making and patient management in Crohn's disease in a tertiary referral center
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lovasz B.D.*1, Gonczi L.1, Kurti Z.1, Vegh Z.1, Golovics P.A.1, Rudas G.2, Gecse K.B.1, Lakatos P.L.1

Created: Wednesday, 20 February 2019, 10:36 AM